Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN35754083
ISRCTN35754083
Completed
Not Applicable

Phase II, double blind, randomised, controlled study to evaluate immunogenicity, reactogenicity and safety of GlaxoSmithKline Biologicals Hib-menAC vaccine (Ghana)

GlaxoSmithKline (GSK) Biologicals (Ancillary study - Swiss Tropical Institute) (Belgium)0 sites280 target enrollmentSeptember 22, 2004
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsVaccination against meningococcal diseaseInfections and InfestationsVaccination

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Vaccination against meningococcal disease
Sponsor
GlaxoSmithKline (GSK) Biologicals (Ancillary study - Swiss Tropical Institute) (Belgium)
Enrollment
280
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 22, 2004
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
GlaxoSmithKline (GSK) Biologicals (Ancillary study - Swiss Tropical Institute) (Belgium)

Eligibility Criteria

Inclusion Criteria

  • •Healthy infants between 6 \- 8 weeks of age at first vaccination.

Exclusion Criteria

  • •Any condition that may affect the health of the subject, or the interpretation of the results.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
A clinical study to evaluate the efficacy to stop the bleeding and safety of TT-173 applied in the donor site of patients undergoing skin graft.
EUCTR2013-002784-25-ESThrombotargets Europe
Completed
Not Applicable
Phase II multi-centre study to evaluate efficacy, safety, and immunogenicity of GMZ2 candidate malaria vaccine in children aged 12 to 60 monthsMalariaPaediatrics
PACTR2010060002033537Statens Serum Intitute1,840
Completed
Phase 2
A phase II study of the Cuban adult formulation tetanus and diphtheria vaccine.tetanus and diphtheriaTetanusDiphtheriaClostridium InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsCorynebacterium InfectionsActinomycetales Infections
RPCEC00000059Finlay Institute225
Completed
Phase 2
A phase II study of the Cuban vaccine against tetanus and diphtheria VA-DIFTET.tetanus and diphtheriaTetanusDiphtheriaClostridium InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsCorynebacterium InfectionsActinomycetales Infections
RPCEC00000058Finlay Institute300
Active, not recruiting
Not Applicable
A phase II, randomized, double-blind, controlled study to evaluate the immune responses, safety and clinical efficacy of three doses of Neovacs’ TNF-Kinoid in adult patients with rheumatoid arthritis who have relapsed despite anti-TNFa biological therapyRheumatoid arthritisMedDRA version: 14.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Immune System Diseases [C20]
EUCTR2009-012041-35-BEeovacs SA48